DE3685988D1 - Verwendung von "naftidrofuryl" zur behandlung von neuropathien. - Google Patents

Verwendung von "naftidrofuryl" zur behandlung von neuropathien.

Info

Publication number
DE3685988D1
DE3685988D1 DE8686400867T DE3685988T DE3685988D1 DE 3685988 D1 DE3685988 D1 DE 3685988D1 DE 8686400867 T DE8686400867 T DE 8686400867T DE 3685988 T DE3685988 T DE 3685988T DE 3685988 D1 DE3685988 D1 DE 3685988D1
Authority
DE
Germany
Prior art keywords
naftidrofuryl
neuropathia
treatment
furanpro
panoate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686400867T
Other languages
English (en)
Other versions
DE3685988T2 (de
Inventor
Michel Mosnier
Marcel Grand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sante SAS
Original Assignee
Merck Sante SAS
LIPHA SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sante SAS, LIPHA SAS filed Critical Merck Sante SAS
Publication of DE3685988D1 publication Critical patent/DE3685988D1/de
Application granted granted Critical
Publication of DE3685988T2 publication Critical patent/DE3685988T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Furan Compounds (AREA)
DE8686400867T 1985-04-23 1986-04-22 Verwendung von "naftidrofuryl" zur behandlung von neuropathien. Expired - Lifetime DE3685988T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8506132A FR2580502B1 (fr) 1985-04-23 1985-04-23 Emploi du " naftidrofuryl " dans la preparation d'un medicament

Publications (2)

Publication Number Publication Date
DE3685988D1 true DE3685988D1 (de) 1992-08-20
DE3685988T2 DE3685988T2 (de) 1993-02-04

Family

ID=9318551

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686400867T Expired - Lifetime DE3685988T2 (de) 1985-04-23 1986-04-22 Verwendung von "naftidrofuryl" zur behandlung von neuropathien.

Country Status (7)

Country Link
US (1) US4652583A (de)
EP (1) EP0202986B1 (de)
JP (1) JPH064535B2 (de)
AT (1) ATE78160T1 (de)
DE (1) DE3685988T2 (de)
FR (1) FR2580502B1 (de)
IE (1) IE59047B1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440928B1 (en) * 1988-12-06 2002-08-27 Colorado State University Research Foundation Method for treating diabetic neuropathy with NGF

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL274986A (de) * 1961-02-23
US3445574A (en) * 1962-09-20 1969-05-20 Lipha Compositions and method for arresting spasms with the diethylaminoethyl ester of beta-(1-naphthyl)-beta'-tetrahydrofurylisobutyric acid
NL142872C (de) * 1963-03-28
FR3843M (fr) * 1964-03-17 1966-01-17 Lipha Nouvelles bases azotées a propriétés antispasmodique et vasodilatatrice.
FR2505836A1 (fr) * 1981-05-14 1982-11-19 Sanofi Sa Citrate de naftidrofuryl et son application therapeutique

Also Published As

Publication number Publication date
FR2580502A1 (fr) 1986-10-24
FR2580502B1 (fr) 1988-07-08
IE59047B1 (en) 1993-12-15
JPS61249921A (ja) 1986-11-07
EP0202986A3 (en) 1990-05-16
US4652583A (en) 1987-03-24
EP0202986B1 (de) 1992-07-15
EP0202986A2 (de) 1986-11-26
IE860892L (en) 1986-10-23
ATE78160T1 (de) 1992-08-15
JPH064535B2 (ja) 1994-01-19
DE3685988T2 (de) 1993-02-04

Similar Documents

Publication Publication Date Title
ATE83659T1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
IT1190466B (it) Procedimento di trattamento per forme farmaceutiche di dosaggio rivestite per ridurne la collosita'
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
SE8703625D0 (sv) New medical use
DE3786893D1 (de) Piperidinderivat zur schmerzbehandlung.
ATE137965T1 (de) Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege
FR2585572B3 (fr) Nouvelles compositions pharmaceutiques a base d'un sel de l'acide p. chlorophenoxyacetique destinees au traitement des neuropathies et assurant la regeneration nerveuse
IT1238825B (it) Dispositivo per la correzione chirurgica dell'ametropia.
DE68904462D1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelial-gewebekrankheiten.
IT9041503A1 (it) Dispositivo per la cura chirurgica dell'ametropia
ATE161725T1 (de) Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina
BR9007115A (pt) Novo trombolitico
DE69111974D1 (de) Verwendung von Lithium zur Behandlung oder Prophylaxe von Molluscum contagiusum.
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
DE69007065D1 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
MY104521A (en) Treatment of depression.
DE3685988D1 (de) Verwendung von "naftidrofuryl" zur behandlung von neuropathien.
PT91415A (pt) Processo para a preparacao de novos derivados de furiltiazol
ATE147978T1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
ATE24834T1 (de) Verwendung von beta-(1-adamantyl)-alpha, alphadimethylethylamin zur herstellung eines arzneimittels zur behandlung von otitis externa bei hunden.
BG46004A3 (en) Method for preparing optical active 2- chlor- 12- (3- dimethylamin- 2- methylpropyl)- 12h- dibenzo- (d, g) (1, 3, 6)- dioxazocini
DE3584426D1 (de) Verwendung von spergualin oder eines seiner pharmazeutisch akzeptablen salze zur herstellung eines transplantation-immunitaet unterdrueckenden und anti-allergischen mittels.
ATE158719T1 (de) Verwendung von hexetidin oder dessen derivaten oder salzen zur herstellung einer pharmazeutischen zusammensetzung für ophthalmische verwendung
ATE74755T1 (de) Verwendung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-am no-5-methylsulfamoylbenzamid zur behandlung der parkinson-krankheit.
IT8919216A0 (it) Dispositivo per la cura chirurgica dell'astigmatismo.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: LIPHA, LYON, FR